Clinical Trials in Georgia

Showing 4261-4280 of 19,050 trials

OCS DCD Heart + CAP Continued Follow-Up

NCT05741723

The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.

Heart Transplant

TransMedics276 participantsStarted Nov 2019

La Jolla, California, United States • Palo Alto, California, United States • New Haven, Connecticut, United States +17 more locations

TERMINATEDPhase 265 miles

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

NCT05306873

The primary purpose of this study is to evaluate the potential effectiveness of 24 weeks of MMF within previously discovered immunologically defined subsets of SLE patients. Treatment effects will be evaluated within the individual immunologically-homogenous subsets defined at screening. This study will also explore and compare pre-randomization gene expression patterns among responders and non-responders to MMF and MMF plus voclosporin, use comprehensive immunophenotyping to study the immunologic changes that accompany treatment- induced disease improvement and to better understand immunologic changes associated with the loss of clinical response.

Systemic Lupus Erythematosus

National Institute of Allergy and Infectious Diseases (NIAID)12 participantsStarted Nov 2022

Los Angeles, California, United States • New Haven, Connecticut, United States • Atlanta, Georgia, United States +7 more locations

OCS DCD Heart + CAP Continued Follow-Up

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

Find Trials by Condition in Georgia

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

A Study of LM-24C5 For Advanced Solid Tumors

ACHIEVE Hearing Intervention Follow-Up Study

Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis

Mindfulness Based Smoking Cessation Among Cancer Survivors

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning